Despite of the emerging new systemic and local oncologic treatments (immunotherapy and checkpoint inhibitors, oncolytic viral treatments and injected immunostimulants) the management of skin melanoma metastasis can be still challenging. The main aim of this review was to assess the efficacy and the role of imiquimod in local metastatic melanoma disease. An extensive literature review was performed from September 2000 to March 2020 using PubMed, MEDLINE, Embase, and Cochrane Library databases. Selected articles regarded topical imiquimod, its mode of action as an antitumoral agent and its applications in melanoma metastases treatment. We analyzed a total of 18 published article of clinical cases and small case series and five studies: two retrospective large case series, two Phase I and II clinical trials and one cohort non randomized study. Generally, the treatment is safe and well tolerated. Imiquimod lead to an unstable locoregional control. The use of topical imiquimod for the treatment of MM cutaneous metastases should be considered in selected cases and in palliative settings.

Scarfì F., Patrizi A., Veronesi G., Lambertini M., Tartari F., Mussi M., et al. (2020). The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature. DERMATOLOGIC THERAPY, 33(6), 1-11 [10.1111/dth.14165].

The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature

Scarfì F.
;
Patrizi A.;Veronesi G.;Lambertini M.;Tartari F.;Mussi M.;Dika E.
2020

Abstract

Despite of the emerging new systemic and local oncologic treatments (immunotherapy and checkpoint inhibitors, oncolytic viral treatments and injected immunostimulants) the management of skin melanoma metastasis can be still challenging. The main aim of this review was to assess the efficacy and the role of imiquimod in local metastatic melanoma disease. An extensive literature review was performed from September 2000 to March 2020 using PubMed, MEDLINE, Embase, and Cochrane Library databases. Selected articles regarded topical imiquimod, its mode of action as an antitumoral agent and its applications in melanoma metastases treatment. We analyzed a total of 18 published article of clinical cases and small case series and five studies: two retrospective large case series, two Phase I and II clinical trials and one cohort non randomized study. Generally, the treatment is safe and well tolerated. Imiquimod lead to an unstable locoregional control. The use of topical imiquimod for the treatment of MM cutaneous metastases should be considered in selected cases and in palliative settings.
2020
Scarfì F., Patrizi A., Veronesi G., Lambertini M., Tartari F., Mussi M., et al. (2020). The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature. DERMATOLOGIC THERAPY, 33(6), 1-11 [10.1111/dth.14165].
Scarfì F.; Patrizi A.; Veronesi G.; Lambertini M.; Tartari F.; Mussi M.; Melotti B.; Dika E.
File in questo prodotto:
File Dimensione Formato  
Dermatologic Therapy - 2020 - Scarf - The role of topical imiquimod in melanoma cutaneous metastases A critical review of.pdf

accesso riservato

Tipo: Versione (PDF) editoriale
Licenza: Licenza per accesso riservato
Dimensione 13.39 MB
Formato Adobe PDF
13.39 MB Adobe PDF   Visualizza/Apri   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/793477
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 21
social impact